Template – Request for compliance check on an agreed paediatric investigation plan (PIP) Par EMA – Inspection
Notice to sponsors on validation and qualification of computerised systems used in clinical trials Par EMA – Inspection
Notice to sponsors on validation and qualification of computerised systems used in clinical trials Par EMA – Regulatory and procedural guidelines
FDA Approves First Non-Antipsychotic Drug to Treat Agitation Associated with Dementia Par FDA – Press releases
FDA Proposes to Exclude Semaglutide, Tirzepatide, and Liraglutide on 503B Bulks List Par FDA – Press releases
